Table 5.
Characteristics | Univariate analysis log-rank | P | Multivariate analysis hazard ratio (95%) | P |
---|---|---|---|---|
Age (year) | ||||
≤65 | 1.047 | 0.306 | ||
>65 | ||||
Gender | ||||
Male | 0.407 | 0.523 | ||
Female | ||||
Lesion sites | ||||
Right | 2.627 | 0.105 | ||
Left | ||||
Architectural features | ||||
Mucus | 3.227 | 0.072 | ||
Nonmucinous | ||||
Tumor diameter | ||||
≤4.5 cm | 0.032 | 0.858 | ||
>4.5 cm | ||||
Invasion | ||||
T1-T2 | 5.579 | 0.018 | NS | |
T3-T4 | ||||
Lymph metastasis | ||||
N0 | 9.773 | 0.002 | NS | |
N1-N2 | ||||
Liver metastasis | ||||
Negative | 5.583 | 0.018 | NS | |
Positive | ||||
TNM stagea | ||||
I-II | 10.983 | 0.001 | 0.391 (0.201–0.760) | 0.006 |
III-IV | 1 | |||
WIF1 and SFRP1 expression | ||||
WIF(+)/SFRP1(+) | 5.477 | 0.019 | 0.428 (0.187–0.983) | 0.045 |
The others | 1 |
aAccording to the 2002 version of the American Joint Committee on Cancer (AJCC) and the International Union Against Cancer (UICC).
NS: variables not significant in the equation, P > 0.05.